#METABOLOMICS WORKBENCH Codreags00_20210603_143951 DATATRACK_ID:2675 STUDY_ID:ST001848 ANALYSIS_ID:AN002992 PROJECT_ID:PR001165
VERSION             	1
CREATED_ON             	June 28, 2021, 1:50 pm
#PROJECT
PR:PROJECT_TITLE                 	Untargeted mass spectrometry reveals impact of high fat diet on peripheral amino
PR:PROJECT_TITLE                 	acid regulation in a mouse model of Alzheimer’s Disease
PR:PROJECT_TYPE                  	Untargeted Metabolomics analysis
PR:PROJECT_SUMMARY               	Recent research regarding amino acid metabolism has shown that there may be a
PR:PROJECT_SUMMARY               	link between obesity and Alzheimer’s Disease (AD). This work reports a
PR:PROJECT_SUMMARY               	metabolomics study using untargeted mass spectrometry-based metabolomic
PR:PROJECT_SUMMARY               	strategies to investigate the metabolic changes that occur in AD and obesity.
PR:PROJECT_SUMMARY               	APPSwe/PS1ΔE9 (APP/PSEN1) transgenic mice (to represent familial or early-onset
PR:PROJECT_SUMMARY               	AD) and wild-type litter mater controls were fed either a high-fat diet (HFD,
PR:PROJECT_SUMMARY               	60% kcal from lard), low-fat diet (LFD, 10% kcal from lard) from 2 months of
PR:PROJECT_SUMMARY               	age, or reversal diet (REV, high-fat followed by low-fat from 9.5 months).
PR:INSTITUTE                     	Vanderbilt University
PR:DEPARTMENT                    	Chemistry
PR:LABORATORY                    	Center for Innovative Technology
PR:LAST_NAME                     	Codreanu
PR:FIRST_NAME                    	Simona
PR:ADDRESS                       	3009, Liberty Hills Drive
PR:EMAIL                         	SIMONA.CODREANU@VANDERBILT.EDU
PR:PHONE                         	6153477458
#STUDY
ST:STUDY_TITLE                   	Untargeted mass spectrometry reveals impact of high fat diet on peripheral amino
ST:STUDY_TITLE                   	acid regulation in a mouse model of Alzheimer’s Disease
ST:STUDY_SUMMARY                 	APPSwe/PS1ΔE9 (APP/PSEN1) transgenic mice (to represent familial or early-onset
ST:STUDY_SUMMARY                 	AD) and wild-type litter mater controls were fed either a high-fat diet (HFD,
ST:STUDY_SUMMARY                 	60% kcal from lard), low-fat diet (LFD, 10% kcal from lard) from 2 months of
ST:STUDY_SUMMARY                 	age, or reversal diet (REV, high-fat followed by low-fat from 9.5 months).
ST:INSTITUTE                     	Vanderbilt University
ST:DEPARTMENT                    	Chemistry
ST:LABORATORY                    	Center for Innovative Technology
ST:LAST_NAME                     	Codreanu
ST:FIRST_NAME                    	Simona
ST:ADDRESS                       	3009, Liberty Hills Drive
ST:EMAIL                         	SIMONA.CODREANU@VANDERBILT.EDU
ST:NUM_GROUPS                    	6
ST:TOTAL_SUBJECTS                	36
ST:NUM_MALES                     	18
ST:NUM_FEMALES                   	18
ST:STUDY_TYPE                    	untargeted metabolomics analysis
ST:PHONE                         	6153477458
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:GENOTYPE_STRAIN               	APPSwe/PS1ΔE9 (APP/PSEN1)
SU:AGE_OR_AGE_RANGE              	12 month
SU:GENDER                        	Male and female
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	958_S01	S01	gender:M | genotype:WT | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_LFD_WT_958_S01
SUBJECT_SAMPLE_FACTORS           	960_S02	S02	gender:M | genotype:WT | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_LFD_WT_960_S02
SUBJECT_SAMPLE_FACTORS           	907_S03	S03	gender:M | genotype:WT | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_LFD_WT_907_S03
SUBJECT_SAMPLE_FACTORS           	959_S04	S04	gender:M | genotype:APP | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_LFD_APP_959_S04
SUBJECT_SAMPLE_FACTORS           	904_S05	S05	gender:M | genotype:APP | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_LFD_APP_904_S05
SUBJECT_SAMPLE_FACTORS           	903_S06	S06	gender:M | genotype:APP | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_LFD_APP_903_S06
SUBJECT_SAMPLE_FACTORS           	1092_S07	S07	gender:M | genotype:WT | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_HFD_WT_1092_S07
SUBJECT_SAMPLE_FACTORS           	909_S08	S08	gender:M | genotype:WT | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_HFD_WT_909_S08
SUBJECT_SAMPLE_FACTORS           	908_S09	S09	gender:M | genotype:WT | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_HFD_WT_908_S09
SUBJECT_SAMPLE_FACTORS           	1091_S10	S10	gender:M | genotype:APP | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_HFD_APP_1091_S10
SUBJECT_SAMPLE_FACTORS           	1090_S11	S11	gender:M | genotype:APP | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_HFD_APP_1090_S11
SUBJECT_SAMPLE_FACTORS           	1162_S12	S12	gender:M | genotype:APP | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_HFD_APP_1162_S12
SUBJECT_SAMPLE_FACTORS           	695_S13	S13	gender:M | genotype:WT | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_REV_WT_695_S13
SUBJECT_SAMPLE_FACTORS           	696_S14	S14	gender:M | genotype:WT | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_REV_WT_696_S14
SUBJECT_SAMPLE_FACTORS           	983_S15	S15	gender:M | genotype:WT | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_REV_WT_983_S15
SUBJECT_SAMPLE_FACTORS           	694_S16	S16	gender:M | genotype:APP | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_REV_APP_694_S16
SUBJECT_SAMPLE_FACTORS           	697_S17	S17	gender:M | genotype:APP | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_REV_APP_697_S17
SUBJECT_SAMPLE_FACTORS           	981_S18	S18	gender:M | genotype:APP | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_M_REV_APP_981_S18
SUBJECT_SAMPLE_FACTORS           	961_S19	S19	gender:F | genotype:WT | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_LFD_WT_961_S19
SUBJECT_SAMPLE_FACTORS           	962_S20	S20	gender:F | genotype:WT | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_LFD_WT_962_S20
SUBJECT_SAMPLE_FACTORS           	964_S21	S21	gender:F | genotype:WT | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_LFD_WT_964_S21
SUBJECT_SAMPLE_FACTORS           	963_S22	S22	gender:F | genotype:APP | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_LFD_APP_963_S22
SUBJECT_SAMPLE_FACTORS           	965_S23	S23	gender:F | genotype:APP | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_LFD_APP_965_S23
SUBJECT_SAMPLE_FACTORS           	984_S24	S24	gender:F | genotype:APP | treatment:LFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_LFD_APP_984_S24
SUBJECT_SAMPLE_FACTORS           	749_S25	S25	gender:F | genotype:WT | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_HFD_WT_749_S25
SUBJECT_SAMPLE_FACTORS           	753_S26	S26	gender:F | genotype:WT | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_HFD_WT_753_S26
SUBJECT_SAMPLE_FACTORS           	1015_S27	S27	gender:F | genotype:WT | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_HFD_WT_1015_S27
SUBJECT_SAMPLE_FACTORS           	750_S28	S28	gender:F | genotype:APP | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_HFD_APP_750_S28
SUBJECT_SAMPLE_FACTORS           	751_S29	S29	gender:F | genotype:APP | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_HFD_APP_751_S29
SUBJECT_SAMPLE_FACTORS           	752_S30	S30	gender:F | genotype:APP | treatment:HFD	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_HFD_APP_752_S30
SUBJECT_SAMPLE_FACTORS           	691_S31	S31	gender:F | genotype:WT | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_REV_WT_691_S31
SUBJECT_SAMPLE_FACTORS           	692_S32	S32	gender:F | genotype:WT | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_REV_WT_692_S32
SUBJECT_SAMPLE_FACTORS           	693_S33	S33	gender:F | genotype:WT | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_REV_WT_693_S33
SUBJECT_SAMPLE_FACTORS           	954_S34	S34	gender:F | genotype:APP | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_REV_APP_954_S34
SUBJECT_SAMPLE_FACTORS           	956_S35	S35	gender:F | genotype:APP | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_REV_APP_956_S35
SUBJECT_SAMPLE_FACTORS           	877_S36	S36	gender:F | genotype:APP | treatment:REV	RAW_FILE_NAME=SC_20190826_RPLCp_FMS_Liv_F_REV_APP_877_S36
#COLLECTION
CO:COLLECTION_SUMMARY            	Liver samples from male and female APPSwe/PS1ΔE9 (APP/PSEN1) transgenic mice
CO:COLLECTION_SUMMARY            	and wild-type (WT) littermates were collected after sacrifice at 12 months.
CO:COLLECTION_SUMMARY            	These mice are a subset of mice for which behavioral and biochemical data have
CO:COLLECTION_SUMMARY            	already been published, including weight change and diabetic state as assessed
CO:COLLECTION_SUMMARY            	by glucose tolerance tests.After sacrifice, liver tissue samples were taken and
CO:COLLECTION_SUMMARY            	put immediately on dry ice and stored at −80°C until used in the analytical
CO:COLLECTION_SUMMARY            	workflow described herein.
CO:SAMPLE_TYPE                   	Liver
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Briefly, at 2-months of age, standard lab chow (Purina 5001, 4% kcal/fat) was
TR:TREATMENT_SUMMARY             	replaced with either HFD in which 60% kcal are derived from lard, 20% from
TR:TREATMENT_SUMMARY             	carbohydrate and 20% from protein, or low-fat diet (LFD) control in which 10%
TR:TREATMENT_SUMMARY             	kcal are derived from lard and additional calories are derived from corn starch,
TR:TREATMENT_SUMMARY             	with 70% from carbohydrates and 20% from protein.33 For the reversal group
TR:TREATMENT_SUMMARY             	(REV), a subset of mice on the HFD was provided with a LFD, at 9.5 months of
TR:TREATMENT_SUMMARY             	age, for the study duration.33 All other mice were maintained on their original
TR:TREATMENT_SUMMARY             	experimental diets until the end of the study, which was an additional 10 weeks.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	For liver samples, frozen tissues were first individually pulverized using a
SP:SAMPLEPREP_SUMMARY            	mortar and pestle followed by lysing in 1 mL ice-cold lysis buffer ((1:1:2,
SP:SAMPLEPREP_SUMMARY            	ACN:MeOH:ammonium bicarbonate (0.1 M, pH 8.0) (LC-MS grade)). Individual samples
SP:SAMPLEPREP_SUMMARY            	were sonicated using a probe tip sonicator, 10 pulses, at 30% power, and cooled
SP:SAMPLEPREP_SUMMARY            	on ice between samples. A bicinchoninic acid (BCA) protein assay was used to
SP:SAMPLEPREP_SUMMARY            	determine the protein concentration for each individual sample and adjusted to a
SP:SAMPLEPREP_SUMMARY            	total amount of protein of 200 µg. For untargeted MS studies, SIL-ISs biotin-D2
SP:SAMPLEPREP_SUMMARY            	and phenylalanine-D8 were added to each sample to assess sample processing steps
SP:SAMPLEPREP_SUMMARY            	(metabolite extraction and reconstitution). Following lysis and addition of
SP:SAMPLEPREP_SUMMARY            	SIL-ISs, protein precipitation was performed by adding 800 µL of ice-cold
SP:SAMPLEPREP_SUMMARY            	methanol (4x by volume). Samples were incubated at -80°C overnight. Following
SP:SAMPLEPREP_SUMMARY            	incubation, samples were centrifuged at 10,000 rpm for 10 min. The supernatant
SP:SAMPLEPREP_SUMMARY            	containing metabolites were dried in vacuo and metabolite extracts were stored
SP:SAMPLEPREP_SUMMARY            	frozen at -80 °C until ready to use.
SP:PROCESSING_STORAGE_CONDITIONS 	-80℃
SP:EXTRACTION_METHOD             	Following lysis and standard addition, protein precipitation was performed by
SP:EXTRACTION_METHOD             	adding 800µL of ice-cold methanol (4x by volume). Samples were incubated at
SP:EXTRACTION_METHOD             	-80°C overnight. Following incubation, samples were centrifuged at 10,000 rpm
SP:EXTRACTION_METHOD             	for 10 min to eliminate proteins. The supernatants containing metabolites were
SP:EXTRACTION_METHOD             	dried via speed-vacuum.
SP:EXTRACT_STORAGE               	-80℃
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Thermo Hypersil Gold Hypersil Gold, 1.9 mm, 2.1 mm x 100 mm
CH:FLOW_GRADIENT                 	0.250
CH:FLOW_RATE                     	0.25 mL/min
CH:COLUMN_TEMPERATURE            	40
CH:SOLVENT_A                     	100% water, 0.1% Formic Acid
CH:SOLVENT_B                     	100% acetonitrile, 0.1% Formic Acid
CH:INJECTION_TEMPERATURE         	8
CH:SAMPLE_INJECTION              	5
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	XCalibur software for data acquisition Progenesis QI 2.0 for data processing
MS:MS_RESULTS_FILE               	ST001848_AN002992_Results.txt	UNITS:time_m/z	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END